The genetic research It allows predicting disease because it identifies people's genetic data. These data allow the doctor to choose the best drug, the right dose with less adverse impact on the patient, resulting in a more personalized medicine.
This was explained by Dr. Heinner Guio, researcher National Institute of Health (INS) and responsible for research on the Peruvian genome. "In some countries, the study of genetics in their populations has identified the risk of developing hypertension.
Another example is the indication of risk-reducing operations (mastectomies) after finding pathogenic mutations in genes related to the development of breast cancer in the disease "- he explained.
In Europe, this system was established, benefiting from it. In Latin America, Mexico was the first country to report its results in 2009, Brazil in 2015, and Peru in 2018. "At INS, we identified nearly 3 million genetic variants that have never been informed. analyzed in various medical specialties in Peru to confirm which of them may have clinical implications.
Currently, there are many genetic tests to diagnose diseases. Our findings will help these trials improve their predictions in our population, "said Guio. In his research, he discovered that the Peruvian mestizo has 60% of the native composition.
"Many of the genetic variants we have found exist in native communities, which is why the population of Peru will be used for these discoveries to improve the identification of disease risk," he explained.
The specialist will present his paper on the Peruvian human genome at the XII International Scientific Congress of INS: Current Challenges of Public Health in Peru ", which will run from 6 to 8 November.